Inhibitor Therapeutics (INTI) Preferred Dividend Payments (2018 - 2022)
Inhibitor Therapeutics' Preferred Dividend Payments came in at $39,452 for Q4 2022, down 21.7% from $50,411 a year earlier and down 21.7% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Preferred Dividend Payments (2018 - 2022) Analysis & Trends
For FY2022, Inhibitor Therapeutics' Preferred Dividend Payments was $189,042, down 5.5% from FY2021.
- Preferred Dividend Payments carries a four-year compound annual growth rate of 4.8% (FY2018 to FY2022).
- Going back by year, Preferred Dividend Payments was $200,001 in FY2021 (-0.3%), $200,548 in FY2020 (+0.3%), $200,000 in FY2019 (+27.8%) and $156,493 in FY2018.
- The Q4 2022 figure represents the lowest quarterly Preferred Dividend Payments since Q2 2018.
- The fastest year-over-year change in Preferred Dividend Payments over five years came in Q1 2019 (growth of 85.2%), and the weakest in Q4 2022 (a decline of 21.7%).
- Business Quant data shows INTI's Preferred Dividend Payments at $50,411 (Q3 2022), $49,863 (Q2 2022) and $49,315 (Q1 2022) in the three quarters before Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Inhibitor Therapeutics | 13.90 Mn | 6.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 39,452.00 |
| Sep 30, 2022 | 50,411.00 |
| Jun 30, 2022 | 49,863.00 |
| Mar 31, 2022 | 49,315.00 |
| Dec 31, 2021 | 50,411.00 |
| Sep 30, 2021 | 50,412.00 |
| Jun 30, 2021 | 49,863.00 |
| Mar 31, 2021 | 49,315.00 |
| Dec 31, 2020 | 50,411.00 |
| Sep 30, 2020 | 50,411.00 |
| Jun 30, 2020 | 49,863.00 |
| Mar 31, 2020 | 49,863.00 |
| Dec 31, 2019 | 50,412.00 |
| Sep 30, 2019 | 50,410.00 |
| Jun 30, 2019 | 49,863.00 |
| Mar 31, 2019 | 49,315.00 |
| Dec 31, 2018 | 50,411.00 |
| Sep 30, 2018 | 49,534.00 |
| Jun 30, 2018 | 29,918.00 |
| Mar 31, 2018 | 26,630.00 |
API Access
Inhibitor Therapeutics Preferred Dividend Payments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-dividend-payments", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();